311 top medical experts on Multiple Endocrine Neoplasia Type 2a across 44 countries and 21 U.S. states, including 172 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Multiple Endocrine Neoplasia Type 2a: A form of multiple endocrine neoplasia characterized by the presence of medullary carcinoma (carcinoma, medullary) of the thyroid gland, and usually with the co-occurrence of pheochromocytoma, producing calcitonin and adrenaline, respectively. Less frequently, it can occur with hyperplasia or adenoma of the parathyroid glands. This disease is due to gain-of-function mutations of the MEN2 gene on chromosome 10 (Locus: 10q11.2), also known as the RET proto-oncogene that encodes a receptor protein-tyrosine kinase. It is an autosomal dominant inherited disease.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Multiple Endocrine Neoplasia (574).
  4. Clinical Trials ClinicalTrials.gov : at least 7 including 1 Active, 3 Completed, 2 Recruiting
  5. Synonyms: MEN 2,  MEN 2a,  Multiple Endocrine Type 2a Neoplasia,  Multiple Endocrine Type 2a Neoplasms,  Sipple Syndrome


  

        

                    


    Computing Expert Listing ...

);